218 related articles for article (PubMed ID: 19818094)
1. Transport characteristics of a novel peptide platform for CNS therapeutics.
Bertrand Y; Currie JC; Demeule M; Régina A; Ché C; Abulrob A; Fatehi D; Sartelet H; Gabathuler R; Castaigne JP; Stanimirovic D; Béliveau R
J Cell Mol Med; 2010 Dec; 14(12):2827-39. PubMed ID: 19818094
[TBL] [Abstract][Full Text] [Related]
2. Two peptides targeting endothelial receptors are internalized into murine brain endothelial cells.
Hudecz D; Sigurdardóttir SB; Christensen SC; Hempel C; Urquhart AJ; Andresen TL; Nielsen MS
PLoS One; 2021; 16(4):e0249686. PubMed ID: 33798235
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2.
Demeule M; Currie JC; Bertrand Y; Ché C; Nguyen T; Régina A; Gabathuler R; Castaigne JP; Béliveau R
J Neurochem; 2008 Aug; 106(4):1534-44. PubMed ID: 18489712
[TBL] [Abstract][Full Text] [Related]
4. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain.
Shao K; Huang R; Li J; Han L; Ye L; Lou J; Jiang C
J Control Release; 2010 Oct; 147(1):118-26. PubMed ID: 20609375
[TBL] [Abstract][Full Text] [Related]
5. Retro-inverso isomer of Angiopep-2: a stable d-peptide ligand inspires brain-targeted drug delivery.
Wei X; Zhan C; Chen X; Hou J; Xie C; Lu W
Mol Pharm; 2014 Oct; 11(10):3261-8. PubMed ID: 24673510
[TBL] [Abstract][Full Text] [Related]
6. Cancer and the blood-brain barrier: 'Trojan horses' for courses?
Mazza M; Uchegbu IF; Schätzlein AG
Br J Pharmacol; 2008 Sep; 155(2):149-51. PubMed ID: 18587417
[TBL] [Abstract][Full Text] [Related]
7. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
Ke W; Shao K; Huang R; Han L; Liu Y; Li J; Kuang Y; Ye L; Lou J; Jiang C
Biomaterials; 2009 Dec; 30(36):6976-85. PubMed ID: 19765819
[TBL] [Abstract][Full Text] [Related]
8. Effect of flow on targeting and penetration of angiopep-decorated nanoparticles in a microfluidic model blood-brain barrier.
Papademetriou I; Vedula E; Charest J; Porter T
PLoS One; 2018; 13(10):e0205158. PubMed ID: 30300391
[TBL] [Abstract][Full Text] [Related]
9. The brain targeting mechanism of Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles.
Xin H; Sha X; Jiang X; Chen L; Law K; Gu J; Chen Y; Wang X; Fang X
Biomaterials; 2012 Feb; 33(5):1673-81. PubMed ID: 22133551
[TBL] [Abstract][Full Text] [Related]
10. New Angiopep-modified doxorubicin (ANG1007) and etoposide (ANG1009) chemotherapeutics with increased brain penetration.
Ché C; Yang G; Thiot C; Lacoste MC; Currie JC; Demeule M; Régina A; Béliveau R; Castaigne JP
J Med Chem; 2010 Apr; 53(7):2814-24. PubMed ID: 20210346
[TBL] [Abstract][Full Text] [Related]
11. Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1.
Bertrand Y; Currie JC; Poirier J; Demeule M; Abulrob A; Fatehi D; Stanimirovic D; Sartelet H; Castaigne JP; Béliveau R
Br J Cancer; 2011 Nov; 105(11):1697-707. PubMed ID: 22027709
[TBL] [Abstract][Full Text] [Related]
12. A filter-free blood-brain barrier model to quantitatively study transendothelial delivery of nanoparticles by fluorescence spectroscopy.
De Jong E; Williams DS; Abdelmohsen LKEA; Van Hest JCM; Zuhorn IS
J Control Release; 2018 Nov; 289():14-22. PubMed ID: 30243824
[TBL] [Abstract][Full Text] [Related]
13. In vitro discrimination of the role of LRP1 at the BBB cellular level: focus on brain capillary endothelial cells and brain pericytes.
Candela P; Saint-Pol J; Kuntz M; Boucau MC; Lamartiniere Y; Gosselet F; Fenart L
Brain Res; 2015 Jan; 1594():15-26. PubMed ID: 25451130
[TBL] [Abstract][Full Text] [Related]
14. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases.
Gabathuler R
Neurobiol Dis; 2010 Jan; 37(1):48-57. PubMed ID: 19664710
[TBL] [Abstract][Full Text] [Related]
15. Revealing Angiopep-2/LRP1 Molecular Interaction for Optimal Delivery to Glioblastoma (GBM).
di Polidoro AC; Cafarchio A; Vecchione D; Donato P; De Nola F; Torino E
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235232
[TBL] [Abstract][Full Text] [Related]
16. Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents.
Cho CF; Wolfe JM; Fadzen CM; Calligaris D; Hornburg K; Chiocca EA; Agar NYR; Pentelute BL; Lawler SE
Nat Commun; 2017 Jun; 8():15623. PubMed ID: 28585535
[TBL] [Abstract][Full Text] [Related]
17. Up-regulating blood brain barrier permeability of nanoparticles via multivalent effect.
Gao X; Qian J; Zheng S; Xiong Y; Man J; Cao B; Wang L; Ju S; Li C
Pharm Res; 2013 Oct; 30(10):2538-48. PubMed ID: 23494145
[TBL] [Abstract][Full Text] [Related]
18. LRP1-upregulated nanoparticles for efficiently conquering the blood-brain barrier and targetedly suppressing multifocal and infiltrative brain metastases.
Guo Q; Zhu Q; Miao T; Tao J; Ju X; Sun Z; Li H; Xu G; Chen H; Han L
J Control Release; 2019 Jun; 303():117-129. PubMed ID: 31026546
[TBL] [Abstract][Full Text] [Related]
19. Magnesium Reduces Blood-Brain Barrier Permeability and Regulates Amyloid-β Transcytosis.
Zhu D; Su Y; Fu B; Xu H
Mol Neurobiol; 2018 Sep; 55(9):7118-7131. PubMed ID: 29383689
[TBL] [Abstract][Full Text] [Related]
20. Delivery of a peptide-drug conjugate targeting the blood brain barrier improved the efficacy of paclitaxel against glioma.
Li Y; Zheng X; Gong M; Zhang J
Oncotarget; 2016 Nov; 7(48):79401-79407. PubMed ID: 27765902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
